Insta
Representative image. (Website/Livestrong)
According to a long-term study conducted over ten years, Indian stent, Yukon Choice PC and Supra Flex, were ‘equally good’ as that of Abbott’s Xience, as reported by Times Of India (TOI).
Abbott, the American multinational healthcare company, leads the market for stents.
The study based on the extended survey of 2,603 patients was published in the journal of AHA (American Heart Association).
In February 2017, Indian government had capped the prices of stents which led to a price reduction of almost 75 per cent. Following this, several multinational companies had threatened to withdraw their stents from the market. In April 2018, Abbott had discontinued selling Xience Alpine Premium stents in India.
The foreign manufacturers claimed that their products were superior to Indian counterparts and therefore deserved a higher price. All these claims stand discredited by the new study.
“We are excited with this first long-term data which is a new milestone and a benchmark for efficacy and safety of DES Worldwide. Yukon Choice PC showing the lowest Stent thrombosis rates compared to Xience and Cypher in 10 years creates a strong testimony that this technology is truly next generation in terms of safety,” said Gurmit Singh Chugh, Managing Director (MD) of Translumina Therapeutics, the manufacturer of Yukon Choice PC.
Also Read:
Support Swarajya's 50 Ground Reports Project & Sponsor A Story
Every general election Swarajya does a 50 ground reports project.
Aimed only at serious readers and those who appreciate the nuances of political undercurrents, the project provides a sense of India's electoral landscape. As you know, these reports are produced after considerable investment of travel, time and effort on the ground.
This time too we've kicked off the project in style and have covered over 30 constituencies already. If you're someone who appreciates such work and have enjoyed our coverage please consider sponsoring a ground report for just Rs 2999 to Rs 19,999 - it goes a long way in helping us produce more quality reportage.
You can also back this project by becoming a subscriber for as little as Rs 999 - so do click on this links and choose a plan that suits you and back us.
Click below to contribute.
Latest